3M Company (Minnesota Mining and Manufacturing Company) - 1993 Annual Report Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 1993. 3M is an integrated enterprise organized into three business sectors: Industrial and Consumer, Information, Imaging and Electronic, and Life Sciences. The company employs 86,168 persons and operates 82 plants in the U.S. and 109 facilities in 44 other countries. The reporting period was characterized by global recessions in Europe and Japan, negative currency effects, and a soft U.S. health care market.
Key Financial Metrics
| Metric (in millions, except per share) | 1993 | 1992 |
|---|---|---|
| Net Sales | $14,020 | $13,883 |
| Net Income | $1,263 | $1,233 |
| Earnings Per Share | $5.82 | $5.63 |
| Operating Income | $1,956 | $1,994 |
| Operating Margin | 14.0% | 14.4% |
| Cost of Goods Sold (as % of sales) | 60.8% | 60.1% |
| Operating Cash Flow | $2,091 | $2,218 |
| Capital Expenditures | $1,112 | $1,225 |
| Long-Term Debt | $796 | $687 |
| Total Assets | $12,197 | $11,955 |
| Current Ratio | 1.9 | 1.9 |
Material Changes vs. Prior Period
- Sales Growth: Worldwide net sales increased 1.0% to $14.020 billion. U.S. sales rose 3% driven by volume, while international sales fell 1% due to a 6% negative currency translation impact.
- Profitability: Operating income decreased 1.9% to $1.956 billion. Net income increased 2.5% to $1.263 billion. Currency effects reduced 1993 net income by approximately $62 million.
- Cost Structure: Cost of goods sold increased to 60.8% of sales (from 60.1%) due to lower selling prices and currency, partially offset by productivity gains. Selling, general, and administrative expenses decreased to 25.2% of sales.
- Debt: Long-term debt increased to $796 million, largely due to a $469 million guarantee of debt for the Employee Stock Ownership Plan (ESOP).
- Shareholder Returns: The company repurchased $706 million of common stock in 1993 (vs. $247 million in 1992), reducing shares outstanding by over 4 million. Dividends were increased to $3.32 per share.
Guidance, Outlook, and Risks
- Outlook: Management expects slightly better global economic growth in 1994, with improvements likely in the second half. However, the pricing environment is expected to remain competitive, and currency fluctuations could negatively impact results.
- Financial Goals: Long-term targets include 10%+ annual earnings per share growth, 20-25% return on stockholders' equity, and 30% of sales from products introduced in the last four years (achieved >25% in 1993).
- Legal Proceedings: The company is a defendant in 3,054 claims (representing 8,842 individuals) regarding silicone gel mammary implants. While a global settlement was announced by other defendants in February 1994, 3M was not included. Management believes insurance coverage is sufficient to recover all liability and costs, posing no material risk.
- Accounting Changes: The company will adopt SFAS No. 112 regarding postemployment benefits in Q1 1994, expected to have a diminimus effect on results.
Investor Verification Checklist
- Currency Impact: Verify the sensitivity of future earnings to U.S. dollar strength, which reduced 1993 income by $62 million.
- Implant Litigation: Monitor the status of discussions regarding the silicone gel mammary implant claims and confirm insurance coverage adequacy.
- Health Care Sector: Assess the impact of U.S. health care reform uncertainty on the Life Sciences sector, which saw operating income decline 8.6%.
- Share Repurchases: Confirm the execution of the new authorization to repurchase up to 12 million shares (pre-split) through February 1995.
- Stock Split: Note the declared two-for-one stock split for shareholders of record on March 15, 1994.